Filing Details
- Accession Number:
- 0001209191-10-011241
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-02-23 12:00:00
- Reporting Period:
- 2010-02-19
- Filing Date:
- 2010-02-23
- Accepted Time:
- 2010-02-23 10:04:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1347178 | Vanda Pharmaceuticals Inc. | VNDA | Pharmaceutical Preparations (2834) | 030491827 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1454241 | Rast Stephanie Irish | 9605 Medical Center Drive, Suite 300 Rockville MD 20850 | Acting Cfo/Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-02-19 | 20,000 | $10.59 | 2,249 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $10.56 to $10.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.